WntResearch is active in biotechnology. Today the main focus is on the development of drug candidates for various metastatic forms of cancer. The research is focused on studying the bodily-specific protein WNT-5a, which has been found to play a crucial role in the proliferation of tumour cells. The products are licensed to various stakeholders in the industry. The head office is in Malmö.

Quotes for WntResearch AB

Right Now

+/-
-0.04
%
-2,96%
Latest
1.31
High
1.35
Low
1.31
Volume
66 819
Turnover (SEK)
88 043
Value (MSEK)
69,2

Board

CEO

  • Anders Rabbe (tf)

Chairman Of The Board

  • Gudrun Anstrén

Board

  • Jan Nilsson
  • Janna Sand-Dejmek
  • Martin Olovsson
  • Peter Ström
  • Tommy Andersson

Videos

Largest Owners

Name Capital % Votes % Date
Avanza Pension 11,93 11,93 2020-09-30
Nordnet Pensionsförsäkring 6,50 6,50 2020-09-30
Kjell Stenberg 3,03 3,03 2020-09-30
Tommy Andersson 2,05 2,05 2020-09-30
Gunvald Berger 1,52 1,52 2020-09-30
Lars-Erik Forsgårdh 1,33 1,33 2020-09-30
Linfan Zhang 0,90 0,90 2020-09-30
Nils Qvarner 0,59 0,59 2020-09-30
Robert Joki 0,57 0,57 2020-09-30
Livförsäkringsbolaget Skandia 0,55 0,55 2020-09-30
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2021-02-08 Bokslutskommuniké 2020

  • 2021-05-06 Årsstämma 2020

  • 2021-05-06 Delårsrapport 2021-Q1

  • 2021-08-19 Delårsrapport 2021-Q2

  • 2021-11-18 Delårsrapport 2021-Q3

  • 2022-02-24 Bokslutskommuniké 2021